Status:

UNKNOWN

COVID-19 Lessons Learned: the Outcome of TOMEKA® Project is to Teach

Lead Sponsor:

University of Kinshasa

Collaborating Sponsors:

University Ghent

Université de Montréal

Conditions:

COVID-19

Eligibility:

All Genders

15-75 years

Brief Summary

Living in Canada and being health-worker in the first line face to COVID-19, investigator outcome is to teach an experience or explain the disease using a review and get people prepared to COVID-19 tr...

Detailed Description

On 12/06/2020 worldwide, COVID-19 affected 7 273 958 confirmed cases with 413 372 deaths, 97 894 confirmed in Canada with 8 048 deaths, 53 666 confirmed cases in Quebec with 5 148 deaths, 4 637 confir...

Eligibility Criteria

Inclusion

  • Fulfill Inclusion criteria and accept
  • COVID-19 patients confirmed
  • be regular on appointments

Exclusion

  • COVID-19 suspected clinically
  • Children
  • refuse to participate

Key Trial Info

Start Date :

September 1 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

September 1 2021

Estimated Enrollment :

800 Patients enrolled

Trial Details

Trial ID

NCT04424940

Start Date

September 1 2020

End Date

September 1 2021

Last Update

June 16 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cliniques Universitaires de Kinshasa

Kinshasa, Democratic Republic of the Congo, BP KIN XI